PIN7 COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS

Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)66024-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)66024-X/fulltext
Section Title :
Section Order : 393
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66024-X&doi=10.1016/S1098-3015(10)66024-X
HEOR Topics :
Tags :
Regions :